The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor Relations to their team. The successful candidate has a foundation of finance and investor relations experience to draw from in developing and implementing investor relations strategy and communications. This role will support the executive leadership team in helping to build relationships with a range of investors and analysts. Ionis is a financially strong company with a robust pipeline and this individual will have the opportunity to have a meaningful impact as the company strives to discover and develop antisense drugs to treat a variety of health conditions, with an emphasis on cardiovascular, metabolic, severe and rare diseases, including neurological diseases and cancer. The Chase Group appreciates and values our continued partnership with Ionis. We are proud to connect this patient focused company with high caliber talent that shares their passion and drive to help the sick people that depend on them.